- Home
- ADVB vs SNSE Comparison
ADVB vs SNSE Comparison
Compare ADVB & SNSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADVB
- SNSE
- Stock Information
- Founded
- ADVB 2014
- SNSE 2005
- Country
- ADVB United States
- SNSE United States
- Employees
- ADVB N/A
- SNSE N/A
- Industry
- ADVB Medical Specialities
- SNSE Biotechnology: Pharmaceutical Preparations
- Sector
- ADVB Health Care
- SNSE Health Care
- Exchange
- ADVB Nasdaq
- SNSE Nasdaq
- Market Cap
- ADVB 9.1M
- SNSE 10.5M
- IPO Year
- ADVB 2025
- SNSE 2021
- Fundamental
- Price
- ADVB $0.42
- SNSE $8.32
- Analyst Decision
- ADVB
- SNSE Strong Buy
- Analyst Count
- ADVB 0
- SNSE 4
- Target Price
- ADVB N/A
- SNSE $72.50
- AVG Volume (30 Days)
- ADVB 371.2K
- SNSE 16.5K
- Earning Date
- ADVB 11-03-2025
- SNSE 08-05-2025
- Dividend Yield
- ADVB N/A
- SNSE N/A
- EPS Growth
- ADVB N/A
- SNSE N/A
- EPS
- ADVB N/A
- SNSE N/A
- Revenue
- ADVB N/A
- SNSE N/A
- Revenue This Year
- ADVB N/A
- SNSE N/A
- Revenue Next Year
- ADVB N/A
- SNSE N/A
- P/E Ratio
- ADVB N/A
- SNSE N/A
- Revenue Growth
- ADVB N/A
- SNSE N/A
- 52 Week Low
- ADVB $0.34
- SNSE $5.00
- 52 Week High
- ADVB $4.10
- SNSE $17.40
- Technical
- Relative Strength Index (RSI)
- ADVB N/A
- SNSE 52.54
- Support Level
- ADVB N/A
- SNSE $7.79
- Resistance Level
- ADVB N/A
- SNSE $9.08
- Average True Range (ATR)
- ADVB 0.00
- SNSE 0.63
- MACD
- ADVB 0.00
- SNSE 0.06
- Stochastic Oscillator
- ADVB 0.00
- SNSE 59.39
About ADVB Advanced Biomed Inc. Common Stock
Advanced Biomed Inc operates through its subsidiaries that are responsible for the main operation and the design and development of the company's primary technologies and products. It has been focusing on the integration of multiple interdisciplinary technologies and established its microfluidic technology platform. Utilizing the physical and molecular biological characteristics of tumor cells, the company has developed various advanced and original research through the joint application of semiconductor technology and biotechnology. devices, A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).